VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CBUS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CBUSCibus, Inc.
$1.39$906M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

CBUS logoCibus, Inc.(CBUS)Earnings, Financials & Key Ratios

CBUS•NASDAQ
$1.42
Price updated Jul 2, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryRoyalty and IP Monetization Vehicles
AboutCibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.Show more
  • Revenue$4M-14.6%
  • EBITDA-$62M+75.5%
  • Net Income-$127M+49.4%
  • EPS (Diluted)-2.78+74.3%
  • Gross Margin-62.76%-162.8%
  • EBITDA Margin-1691.15%+71.3%
  • Operating Margin-1853.92%+69.4%
  • Net Margin-3492.31%+40.8%
  • ROE-212.41%-84.3%

CBUS Price & Volume

Cibus, Inc. (CBUS) stock price & volume — 10-year historical chart

Loading chart...

Persistent Cash Burn Challenges Cibus Growth Trajectory

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Critical liquidity and dilution

Key Thesis Takeaways

  • Cibus faces a precarious financial outlook characterized by erratic, milestone-dependent revenue and a structural inability to cover R&D costs, which reached $8.7M in 2026Q1 against only $1.7M in revenue.
  • The company's reliance on external capital is underscored by a rapidly eroding equity base, which fell from $293.5M in 2023Q4 to $35.5M by 2026Q1.
  • Investors should remain cautious as the firm's high debt-to-equity ratio of 7.78 and persistent negative operating margins suggest significant liquidity and dilution risks in the near term.

Verdict Logic

the company's persistent cash burn and the erosion of its equity base to $35.5M in 2026Q1 present an unsustainable risk profile for long-term investors.

CBUS Growth Metrics

Cibus, Inc. (CBUS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years11.08%
5 Years-31.34%
3 Years185.12%
TTM-9.79%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM63.1%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM84.82%

Return on Capital

10 Years-61.21%
5 Years-70.01%
3 Years-66.55%
Last Year-21.82%

CBUS Recent Earnings

Cibus, Inc. (CBUS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 14, 2026
Metric
Actual
Est
EPS
$0.33+5.7%
$0.35
Rev
$2M+4.7%
$2M
Q2 2026
Mar 17, 2026
Metric
Actual
Est
EPS
$0.42+2.3%
$0.43
Rev
$1M-35.7%
$2M
Q4 2025
Nov 13, 2025
Metric
Actual
Est
EPS
$0.44-7.3%
$0.41
Rev
$615,000-62.6%
$2M
Q3 2025
Aug 14, 2025
Metric
Actual
Est
EPS
$0.61+11.6%
$0.69
Rev
$933,000-38.3%
$2M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 14, 2026
$0.33vs $0.35+5.7%
$2Mvs $2M+4.7%
Q2 2026Mar 17, 2026
$0.42vs $0.43+2.3%
$1Mvs $2M-35.7%
Q4 2025Nov 13, 2025
$0.44vs $0.41-7.3%
$615,000vs $2M-62.6%
Q3 2025Aug 14, 2025
$0.61vs $0.69+11.6%
$933,000vs $2M-38.3%
Based on last 12 quarters of dataView full earnings history →

Latest CBUS News

Recent stock market news and headlines for Cibus, Inc. (CBUS)

GlobeNewsWire·Jun 17, 2026
Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus

Under new EU rules, crops improved without adding foreign DNA will be treated like conventionally bred crops, validating the approach Cibus has developed for 25 years Under new EU rules, crops improved without adding foreign DNA will be treated like conventionally bred crops, validating the approach Cibus has developed for 25 years

Peers Comparison

Key metrics vs top competitors for Cibus, Inc. (CBUS)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
CBUS logoCBUSCibus, Inc.Current
$1.42$925.87M-0.51-14.62%-3492.31%-212.41%—
PGEN logoPGENPrecigen, Inc.
$5.25$1.58B-3.72146.73%-646.99%-1768.51%—
RKDA logoRKDAArcadia Biosciences, Inc.
$0.75$1.16M-0.44-3.71%-195.94%-219.35%—
SEED logoSEEDOrigin Agritech Limited
$1.08$8.05M-1.04-19.48%-23.07%——
APLD logoAPLDApplied Digital Corporation
$35.52$10.15B-30.6257.74%-52.41%-11.99%—
OFIX logoOFIXOrthofix Medical Inc.
$9.35$377.94M-4.102.85%-7.27%-13.44%—

Compare CBUS vs Peers

Cibus, Inc. (CBUS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PGEN

Most directly comparable listed peer for CBUS.

Scale Benchmark

vs DE

Larger-name benchmark to compare CBUS against a more recognizable public peer.

Peer Set

Compare Top 5

vs PGEN, RKDA, SEED, APLD

CBUS SEC Filings & Documents

Cibus, Inc. (CBUS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 14, 2026·SEC

Material company update

Apr 10, 2026·SEC

Material company update

Mar 27, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 17, 2026·SEC

FY 2025

Mar 20, 2025·SEC

FY 2024

Mar 21, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 14, 2026·SEC

FY 2025

Nov 13, 2025·SEC

FY 2025

Aug 14, 2025·SEC

Get notified when CBUS posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CBUS Frequently Asked Questions

Cibus, Inc. (CBUS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Cibus, Inc.'s revenue?

Cibus, Inc. (CBUS) reported $4.3M in revenue for fiscal year 2025. This represents a 237% increase from $1.3M in 2015.

How fast is Cibus, Inc. growing?

Cibus, Inc. (CBUS) saw revenue decline by 14.6% over the past year.

Is CBUS profitable?

Cibus, Inc. (CBUS) reported a net loss of $101.4M for fiscal year 2025.

Dividend & Returns
What is CBUS's return on equity?

Cibus, Inc. (CBUS) has a return on equity (ROE) of -212.4%. Negative ROE indicates the company is unprofitable.

What is Cibus, Inc.'s free cash flow?

Cibus, Inc. (CBUS) had negative free cash flow of $50.7M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in CBUS back in 2015?

Total return calculator · dividends reinvested · 11+ years of data

See returns →